文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

皮肤软组织感染的急诊处置与院内资源利用

Emergency department disposition and hospital-based resource utilization for skin and soft tissue infections.
PubMed 文献 · Am J Emerg Med · 2026-09-11
一句话结论成人皮肤软组织感染中,急诊处置与后续临床病程大体一致,不一致主要反映为住院时间延长,而非高急诊事件或早期再入院。

这项回顾性区域队列纳入5567例成人皮肤软组织感染急诊病例,主要复合终点为超出常规门诊管理的院内医疗需求(住院者:住院>48小时、ICU、手术干预、非家庭出院、死亡;出院者:72小时内再就诊并住院)。18.6%住院,15.1%达到主要终点(住院者70.8%,出院者2.4%)。住院者中住院>48小时和非家庭出院最常见。高龄、糖尿病(OR 1.65)、慢性肾病(OR 1.34)、淋巴水肿(OR 1.85)、近期SSTI相关医疗接触(OR 1.64)和SIRS(OR 4.43)与主要终点风险升高相关;非西班牙裔黑人(OR 0.52)、头颈部SSTI(OR 0.67)和切开引流(OR 0.16)与风险降低相关。

要点

  • 在5567例成人SSTI急诊病例中,18.6%住院,15.1%达到主要复合终点;住院者中70.8%达标,出院者仅2.4%达标。
  • 住院者中住院>48小时和非家庭出院是最常见事件,提示不一致主要反映为住院时间延长而非高急诊事件。
  • SIRS与主要终点风险升高相关(OR 4.43;95%CI 3.59-5.47),糖尿病(OR 1.65;95%CI 1.37-1.98)、淋巴水肿(OR 1.85;95%CI 1.36-2.53)亦相关。
  • 切开引流与主要终点风险降低相关(OR 0.16;95%CI 0.11-0.25),非西班牙裔黑人(OR 0.52;95%CI 0.37-0.75)和头颈部SSTI(OR 0.67;95%CI 0.46-0.98)亦与风险降低相关。
  • 研究支持对部分住院患者采用门诊路径,并加强对高风险出院者的随访。

适用人群与场景

  • 成人(年龄未在原文具体说明)皮肤软组织感染急诊病例,来自回顾性区域队列;纳入和排除标准原文未详细提及。

诊断标准与关键阈值

  • 主要复合终点:住院者满足住院时间>48小时、入住ICU、手术干预、非家庭出院或死亡之一;出院者满足72小时内再就诊并住院。

处置流程与药物剂量

  • 原文未提及具体药物剂量、给药途径或处置流程细节。

红旗征与不能漏的情况

  • 原文未提及需要立刻处理或不能漏诊的具体红旗征及处理。

研究设计与关键结果

  • 回顾性区域队列纳入5567例成人SSTI急诊病例,18.6%住院,15.1%达到主要复合终点(住院者70.8%,出院者2.4%)。
  • 住院者中住院>48小时和非家庭出院是最常见事件。
  • 多因素logistic回归显示:高龄(原文未给具体OR)、糖尿病(OR 1.65;95%CI 1.37-1.98)、慢性肾病(OR 1.34;95%CI 1.08-1.68)、淋巴水肿(OR 1.85;95%CI 1.36-2.53)、近期SSTI相关医疗接触(OR 1.64;95%CI 1.35-1.99)、SIRS(OR 4.43;95%CI 3.59-5.47)与主要终点风险升高相关。
  • 非西班牙裔黑人(OR 0.52;95%CI 0.37-0.75)、头颈部SSTI(OR 0.67;95%CI 0.46-0.98)、切开引流(OR 0.16;95%CI 0.11-0.25)与主要终点风险降低相关。

证据类型、等级与局限

  • 证据类型:回顾性区域队列研究;证据等级或推荐强度原文未提及。
  • 局限:回顾性设计、单区域队列,可能存在未测量混杂;原文未提及其他局限。

对床旁实践的改变

  • 研究结果支持对部分SSTI住院患者采用门诊路径,并加强对高风险出院者的随访;具体适用与不适用人群原文未明确界定。
  • 急诊处置与后续临床病程大体一致,不一致主要反映为住院时间延长,而非高急诊事件或早期再入院,提示应关注住院时间延长风险而非仅高急诊事件。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Skin/soft tissue infections (SSTIs) are common emergency department (ED) presentations with substantial healthcare costs. When determining ED disposition, clinicians must balance risks of treatment failure against overusing hospitalization. Existing risk-stratification strategies target inpatient or outpatient subgroups and morbidity/mortality outcomes, leaving evidence gaps addressing the complete case mix and hospital-based resource utilization.

METHODS: In this retrospective regional cohort of adult SSTI cases, the primary composite outcome captured hospital-based care requirements exceeding routine outpatient management across hospitalized (length of stay [LOS] >48 h, intensive care, operative intervention, discharge to non-residence, death) and discharged (72 h return with hospitalization) subjects. Logistic regression estimated associations between exposures and outcomes, including disposition-stratified subgroups.

RESULTS: Among 5567 subjects, 18.6% were hospitalized and 15.1% met the primary outcome (hospitalizations: 70.8%; discharges: 2.4%). In hospitalized subjects, LOS >48 h and discharge to non-residence were the most common events. Older age, diabetes (OR 1.65; 95% CI 1.37-1.98), chronic kidney disease (OR 1.34; 95% CI 1.08-1.68), lymphedema (OR 1.85; 95% CI 1.36-2.53), recent SSTI-related healthcare encounter (OR 1.64; 95% CI 1.35-1.99), and systemic inflammatory response syndrome (OR 4.43; 95% CI 3.59-5.47) were associated with higher odds of the primary outcome. Non-Hispanic Black race (OR 0.52; 95% CI 0.37-0.75), head/neck SSTI location (OR 0.67; 95% CI 0.46-0.98), and incision and drainage (OR 0.16; 95% CI 0.11-0.25) were associated with lower odds.

CONCLUSIONS: ED disposition largely aligned with subsequent clinical course. Discordance primarily reflected prolonged LOS rather than high-acuity events or early return visits with hospitalization. These findings support outpatient pathways for selected admissions and improved follow-up for higher-risk discharges.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Reynolds JC, Lund NC, Xia J, et al. Emergency department disposition and hospital-based resource utilization for skin and soft tissue infections. Am J Emerg Med. 2026. PMID: 42759235. doi:10.1016/j.ajem.2026.08.058

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。